Abstract
Background:
There is currently no effective treatment for advanced hepatocellular carcinoma (HCC), and chemotherapy has little effect on long-term survival of HCC patients, largely due to the cancer stem cell (CSC) chemoresistance of HCC.
Methods:
We constructed a small-molecule nanometer-sized prodrug (nanoprodrug) loaded with salinomycin (SAL) for the treatment of HCC. SAL was encapsulated by the prodrug LA-SN38 (linoleic acid modified 7-ethyl-10-hydroxycamptothecin) to construct a self-assembled nanoprodrug further PEGylated with DSPE-PEG2000. We characterized this codelivered nanoprodrug and its antitumor activity both in vitro in human HCC cell lines and in vivo in mice.
Results:
Delivery of the SAL- and LA-SN38-based nanoprodrugs effectively promoted apoptosis of HCC cells, exerted inhibition of HCC tumor-sphere formation as well as HCC cell motility and invasion, and reduced the proportion of CD133+ HCC-CSC cells. In nude mice, the nanoprodrug suppressed growth of tumor xenografts derived from human cell lines and patient.
Conclusion:
Our results show that SAL-based nanoprodrugs are a promising platform for treating patients with HCC and a novel strategy for combination therapy of cancers.
Keywords:
cancer stem cells; hepatocellular carcinoma; salinomycin; self-assemble; small-molecule prodrugs.
© 2020 Wang et al.
MeSH terms
-
Animals
-
Antineoplastic Agents / chemistry
-
Antineoplastic Agents / pharmacology*
-
Antineoplastic Agents / therapeutic use
-
Carcinoma, Hepatocellular / drug therapy*
-
Carcinoma, Hepatocellular / pathology
-
Cell Line, Tumor
-
Humans
-
Irinotecan / analogs & derivatives*
-
Irinotecan / chemistry
-
Irinotecan / pharmacology
-
Irinotecan / therapeutic use
-
Linoleic Acid / chemistry
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / pathology
-
Male
-
Mice, Inbred BALB C
-
Mice, Nude
-
Nanoparticles / chemistry
-
Neoplastic Stem Cells / drug effects
-
Neoplastic Stem Cells / pathology
-
Phosphatidylethanolamines / chemistry
-
Polyethylene Glycols / chemistry
-
Prodrugs / chemistry
-
Prodrugs / pharmacology*
-
Prodrugs / therapeutic use
-
Pyrans / administration & dosage
-
Pyrans / pharmacology*
-
Xenograft Model Antitumor Assays
Substances
-
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy-poly(ethylene glycol 2000)
-
Antineoplastic Agents
-
LA-SN38
-
Phosphatidylethanolamines
-
Prodrugs
-
Pyrans
-
Polyethylene Glycols
-
salinomycin
-
Irinotecan
-
Linoleic Acid
Grants and funding
This work was supported by the National S&T Major Project (No. 2017ZX10203205), the National Natural Science Foundation of China (No. 81801824), the Key Research & Development Plan of Zhejiang Province (No. 2019C03050) and the Major Science and Technology Project of Zhejiang Province (No. 2018C04010).